McDonald's shares underperformed in 2024, likely due to the rise of GLP-1 medications. Learn why MCD stock is a Sell.

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...

Research reveals groundbreaking results about Mounjaro and Ozempic in weight loss treatment. Here's what you need to know ...

For the first time in over a decade, obesity rates have dropped in the United States. A recent study by the CDC showed that ...

The most negatively impacted sectors are frozen, refrigerated, general food and beverages. Circana found GLP-1 users’ monthly ...

One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

随着2024年这些突破性临床试验的相继发表，GLP-1类药物展现出远超预期的治疗潜力。从最初的糖尿病治疗，到减重管理，再到阿尔茨海默病、心血管疾病、慢性肾病、骨关节炎、多囊卵巢综合征等多个重大疾病领域，这类药物正在重新定义现代医学的治疗范式。特别值得 ...

Hello, Health Rounds Readers! Today we feature a study that found yet another potential health benefit of GLP-1 drugs, this ...

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...

A top NYC weight-loss doctor shared the surprising skin complication that he’s encountered in patients using GLP-1 drugs like ...